Type 2 Diabetes Trial, Recruiting (NCT07241221)

Type 2 Diabetes Trial, Recruiting NCT07241221 Sponsor: National University Hospital, Singapore Condition: Type 2 Diabetes

Printed from Voxsanity (voxsanity.com.au) — NCT07241221 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Type 2 Diabetes

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a pregnant woman between 21 and 45 years old at the time of signing up
You are carrying a single baby (not twins or more), and the pregnancy is healthy and progressing normally
Your pregnancy is between 12 weeks and 16 weeks and 6 days along when you sign up
You have been diagnosed with Type 2 diabetes, confirmed by a specific blood sugar test (either before pregnancy or within the first 16 weeks of this pregnancy)
You plan to receive your pregnancy care and give birth at NUH (National University Hospital)
You are willing to sign a consent form agreeing to take part
You are able to swallow capsules and follow the steps required by the trial

Who may not be able to join:

Your baby has been found or is suspected to have a chromosomal condition or a physical or genetic abnormality (confirm with trial site)
You have a severe allergy to certain foods that means you need to carry an EpiPen with you at all times

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Shiao-Yng Chan, MBBChir (UK), FRCOG (UK), PhD, National University of Singapore, National University Hospital Singapore, Institute for Human Development and Potential (A*STAR)

Phone: +65 6516 4134

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07241221

Sponsor: National University Hospital, Singapore

Phase: Not Applicable

Status: Recruiting

Condition: Type 2 Diabetes

Trial contact: +65 6516 4134

More information: https://clinicaltrials.gov/study/NCT07241221

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a pregnant woman between 21 and 45 years old at the time of signing up
You are carrying a single baby (not twins or more), and the pregnancy is healthy and progressing normally
Your pregnancy is between 12 weeks and 16 weeks and 6 days along when you sign up
You have been diagnosed with Type 2 diabetes, confirmed by a specific blood sugar test (either before pregnancy or within the first 16 weeks of this pregnancy)
You plan to receive your pregnancy care and give birth at NUH (National University Hospital)
You are willing to sign a consent form agreeing to take part
You are able to swallow capsules and follow the steps required by the trial

Who may not be able to join:

Your baby has been found or is suspected to have a chromosomal condition or a physical or genetic abnormality (confirm with trial site)
You have a severe allergy to certain foods that means you need to carry an EpiPen with you at all times

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

National University Hospital, Singapore

Registry

ClinicalTrials.gov

Start date

1 December 2025

Est. completion

31 August 2028

Where this trial is recruiting

🇸🇬 Singapore

Primary endpoints

Composite of fetal/neonatal wellbeing

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov